1 Bernier MO, Withrow DR, Berrington de Gonzalez A, et al. Trends in pediatric thyroid cancer incidence
in the United States, 1998–2013. Cancer. 2019;125(14):2497–2505. doi:10.1002/cncr.32125.
2 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBO-
3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 CAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [published correction
appears in CA Cancer J Clin. 2020 Jul;70(4):313]. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/
caac.21492.
Galuppini F, Vianello F, Censi S, et al. Differentiated Thyroid Carcinoma in Pediatric Age: Genetic and
Clinical Scenario. Front Endocrinol (Lausanne). 2019;10:552. doi:10.3389/fendo.2019.00552.
Luzón-Toro B, Fernández RM, Villalba-Benito L, Torroglosa A, Antiñolo G, Borrego S. Influencers on Thyroid Cancer Onset: Molecular Genetic Basis. Genes (Basel). 2019;10(11):913. doi:10.3390/genes10110913.
Slijepcevic N, Zivaljevic V, Paunovic I, et al. Rising incidence of thyroid cancer in Serbia. Hippokratia.
2016;20(1):9–23.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/
caac.21551.
Abdullah MI, Junit SM, Ng KL, Jayapalan JJ, Karikalan B, Hashim OH. Papillary Thyroid Cancer: Genetic
Alterations and Molecular Biomarker Investigations. Int J Med Sci. 2019;16(3):450–460. doi:10.7150/
ijms.29935.
Pan JJ, Zhao L, Cheng R, Yang Y, Hu YH. Thyroid carcinoma in children and adolescents: Clinical
characteristics and follow-up from two centers. J Cancer Res Ther. 2017;13(4):715–719. doi:10.4103/jcrt.
JCRT_167_16.
Shuwen H, Xi Y, Miao D, Jiamin X, Jing Z, Weili G. Nine Genes Mediate the Therapeutic Effects of Iodine-131 Radiotherapy in Thyroid Carcinoma Patients. Dis Markers. 2020;2020:9369341.
doi:10.1155/2020/9369341.
Hjiyej LA, Aschawa H, Mellouki I, Anwar W. Iodine-131 therapy for thyroid cancers: estimation of radiation
doses received by relatives and contact restriction times. Radioprotection. 2019;54(1):55–59. doi:10.1051/
radiopro/2019001.
Yu Y, Wang S, Zhang X, et al. Clinical implications of TPO and AOX1 in pediatric papillary thyroid
carcinoma. Transl Pediatr. 2021;10(4):723–732. doi:10.21037/tp-20-301.
Wang H, Correa H, Sanders M, Neblett WW, Liang J. Noninvasive Follicular Thyroid Neoplasm With
Papillary-Like Nuclear Features in Children: An Institutional Experience and Literature Review. Pediatr
Dev Pathol. 2020;23(2):121–126. doi:10.1177/1093526619866584.
Almosallam OI, Aseeri A, Alhumaid A, AlZahrani AS, Alsobhi S, AlShanafey S. Thyroid surgery in 103
children in a single institution from 2000–2014. Ann Saudi Med. 2020;40(4):316–320. doi:10.5144/02564947.2020.316.
Diklic´ A, Zivaljevic´ V, Paunovic´ I, Kalezic´ N, Tatic´ S. Surgical procedures in patients with thyroid autoimmune disease [in Serbian]. Srp Arh Celok Lek. 2005;133(Suppl 1):77–83. doi:10.2298/sarh05s1077d.
Bogdanova TI, Zurnadzhy LY, Nikiforov YE, et al. Histopathological features of papillary thyroid
carcinomas detected during four screening examinations of a Ukrainian-American cohort. Br J Cancer.
2015;113(11):1556–1564. doi:10.1038/bjc.2015.372.
Faul F, Erdfelder E, Buchner A, Lang AG. Statistical power analyses using G*Power 3.1: tests for correlation
and regression analyses. Behav Res Methods. 2009;41(4):1149–1160. doi:10.3758/BRM.41.4.1149.
Ravishankar U, Pande S, Savita N. I-131 in the management of differentiated thyroid cancer – an update on
current recommendations and practices. Apollo Med. 2009;6(4):347–354. doi:10.1016/S0976-0016(11)60086-0.
Sherman SI. Thyroid carcinoma. Lancet. 2003;361(9356):501–511. doi:10.1016/s0140-6736(03)12488-9.
Zivancevic Simonovic S, Mijatovic Teodorovic Lj. Malignant tumors – selected chapters. In: Ilic M, ed.
Malignant tumors of the thyroid gland. Kragujevac; 2012.
Caron NR, Clark OH. Well differentiated thyroid cancer. Scand J Surg. 2004;93(4):261–271.
doi:10.1177/145749690409300403.
van Tol KM, de Vries EG, Dullaart RP, Links TP. Differentiated thyroid carcinoma in the elderly. Crit Rev
Oncol Hematol. 2001;38(1):79–91. doi:10.1016/s1040-8428(00)00127-x.
Zivaljevic V, Jovanovic M, Perunicic V, Paunovic I. Surgical treatment of metastasis to the thyroid gland:
a single center experience and literature review. Hippokratia. 2018;22(3):137–140.
Dean DS, Gharib H. Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab.
2008;22(6):901–911. doi:10.1016/j.beem.2008.09.019.
Rubello D, Pelizzo MR, Al-Nahhas A, et al. The role of sentinel lymph node biopsy in patients with
Nagoya J. Med. Sci. 85. 733–744, 2023
743
doi:10.18999/nagjms.85.4.733
Vladimir Pantelic et al
differentiated thyroid carcinoma. Eur J Surg Oncol. 2006;32(9):917–921. doi:10.1016/j.ejso.2006.03.018.
Salvatori M, Saletnich I, Rufini V, et al. Severe thyrotoxicosis due to functioning pulmonary metastases of
well-differentiated thyroid cancer. J Nucl Med. 1998;39(7):1202–1207.
26 Sheppard MC, Franklyn JA. Management of the single thyroid nodule. Clin Endocrinol (Oxf).
1992;37(5):398–401. doi:10.1111/j.1365-2265.1992.tb02348.x.
27 Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and
differentiated thyroid cancer. Thyroid. 2006;16(2):109–142. doi:10.1089/thy.2006.16.109.
28 Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology,
and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002;23(1):38–89. doi:10.1210/
edrv.23.1.0455.
29 Sancho JJ, Lennard TW, Paunovic I, Triponez F, Sitges-Serra A. Prophylactic central neck disection in papillary thyroid cancer: a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks
Arch Surg. 2014;399(2):155–163. doi:10.1007/s00423-013-1152-8.
30 Sawka AM, Brierley JD, Tsang RW, et al. An updated systematic review and commentary examining the
effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer. Endocrinol Metab
Clin North Am. 2008;37(2):457–480. doi:10.1016/j.ecl.2008.02.007.
31 Eilsberger F, Hartenstein ML, Librizzi D, et al. Score-based improvement of the indication for surgical
treatment of thyroid lesions. Nuklearmedizin. 2020;59(3):256–259. doi:10.1055/a-1139-9015.
References End
25 Nagoya J. Med. Sci. 85. 733–744, 2023
744
doi:10.18999/nagjms.85.4.733
...
論文の公開元へ
